Submissions for variant NM_001378454.1(ALMS1):c.10892G>A (p.Arg3631His)

gnomAD frequency: 0.00061  dbSNP: rs142558799

Total submissions: 10

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000766969	SCV000533001	uncertain significance	not provided	2025-04-25	criteria provided, single submitter	clinical testing	Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000431898	SCV000713800	uncertain significance	not specified	2017-12-21	criteria provided, single submitter	clinical testing	Variant classified as Uncertain Significance - Favor Benign. The p.Arg3632His va riant in ALMS1 gene has not been previously reported in individuals with hearing loss or Alstrom syndrome, but has been identified in several populations by the Genome Aggregation Database with the highest frequency of 0.21%(51/24014) of Af rican chromosomes (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs142558799). This variant has also been reported in an affected individual of unspecified ph enotypes in ClinVar (Variation ID: 390222). Computational prediction tools and c onservation analysis do not provide strong support for or against an impact to t he protein. In summary, while the clinical significance of the p.Arg3630His vari ant is uncertain, the frequency data indicate that it is more likely to be benig n. ACMG/AMP criteria applied: BS1_supporting.
Labcorp Genetics (formerly Invitae), Labcorp	RCV001086177	SCV000756144	likely benign	Alstrom syndrome	2025-02-03	criteria provided, single submitter	clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000431898	SCV000864101	uncertain significance	not specified	2025-02-22	criteria provided, single submitter	clinical testing
Genetic Services Laboratory, University of Chicago	RCV000431898	SCV002070959	uncertain significance	not specified	2021-11-16	criteria provided, single submitter	clinical testing
Ambry Genetics	RCV002418323	SCV002725509	likely benign	Cardiovascular phenotype	2021-05-09	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago	RCV001086177	SCV003920004	uncertain significance	Alstrom syndrome	2021-03-30	criteria provided, single submitter	clinical testing	ALMS1 NM_015120.4 exon 16 p.Arg3630His (c.10889G>A): This variant has not been reported in the literature and is present in 0.2% (51/24014) of African alleles in the Genome Aggregation Database (http://gnomad-old.broadinstitute.org/variant/2-73799896-G-A). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. However, the variant amino acid Histidine (His) is present in two species (dolphin, killer whale). In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Natera, Inc.	RCV001086177	SCV001459599	likely benign	Alstrom syndrome	2020-06-05	no assertion criteria provided	clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)	RCV000766969	SCV001798036	uncertain significance	not provided		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV000766969	SCV001967530	uncertain significance	not provided		no assertion criteria provided	clinical testing